Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Latest filing published 12 Aug 2026 for TAKEDA PHARMACEUTICAL CO LTD, €309k.
Filing timeline
BuySaleElaine Mary Shannon
Insider track record
Disclosed buys
0
Disclosed sells
2
Signal history
Elaine Mary Shannon: trading record in brief
All filings by Elaine Mary Shannon on record concern Takeda Pharmaceutical Co Ltd. Between 1 July 2026 and 11 August 2026, the trades on record add up to 3 filings.
Every open-market trade on record is a sale: 2 sales worth €368k. Other entries cover 1 share grant.
The latest filing, published on 12 August 2026, reports an open-market sale of €309k in Takeda Pharmaceutical Co Ltd. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Elaine Mary Shannon
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
20,363 shares@ US$17.550.0006% mcap84.0% of flowAmerican Depositary SharesSEC:0001493152-26-037352:0
3,978 shares@ US$17.100.0001% mcap16.0% of flowAmerican Depositary SharesSEC:0001493152-26-037499:0
30,094 shares0American Depositary SharesSEC:0001395064-26-000249:0
3 of 3 declarations
